101 related articles for article (PubMed ID: 11798062)
1. Evaluation of ethnic minorities and gender effects in clinical trials: opportunities lost and rediscovered.
Moyé LA; Powell JH
J Natl Med Assoc; 2001 Dec; 93(12 Suppl):29S-34S. PubMed ID: 11798062
[TBL] [Abstract][Full Text] [Related]
2. Rudiments of subgroup analyses.
Moyé LA
Prog Cardiovasc Dis; 2012; 54(4):338-42. PubMed ID: 22226001
[TBL] [Abstract][Full Text] [Related]
3. Trials within trials: confirmatory subgroup analyses in controlled clinical experiments.
Moyé LA; Deswal A
Control Clin Trials; 2001 Dec; 22(6):605-19. PubMed ID: 11738119
[TBL] [Abstract][Full Text] [Related]
4. An overview of statistical planning to address subgroups in confirmatory clinical trials.
Koch GG; Schwartz TA
J Biopharm Stat; 2014; 24(1):72-93. PubMed ID: 24392979
[TBL] [Abstract][Full Text] [Related]
5. An overview of statistical and regulatory issues in the planning, analysis, and interpretation of subgroup analyses in confirmatory clinical trials.
Hemmings R
J Biopharm Stat; 2014; 24(1):4-18. PubMed ID: 24392975
[TBL] [Abstract][Full Text] [Related]
6. Hispanic research: implications of the National Institutes of Health guidelines on inclusion of women and minorities in clinical research.
Caban CE
J Natl Cancer Inst Monogr; 1995; (18):165-9. PubMed ID: 8562217
[TBL] [Abstract][Full Text] [Related]
7. Primer: the fallacy of subgroup analysis.
Guillemin F
Nat Clin Pract Rheumatol; 2007 Jul; 3(7):407-13. PubMed ID: 17599075
[TBL] [Abstract][Full Text] [Related]
8. Subgroups: time to go back to basic statistical principles?
Keene ON; Garrett AD
J Biopharm Stat; 2014; 24(1):58-71. PubMed ID: 24392978
[TBL] [Abstract][Full Text] [Related]
9. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test.
Brookes ST; Whitely E; Egger M; Smith GD; Mulheran PA; Peters TJ
J Clin Epidemiol; 2004 Mar; 57(3):229-36. PubMed ID: 15066682
[TBL] [Abstract][Full Text] [Related]
10. Biostatistics primer: what a clinician ought to know: subgroup analyses.
Barraclough H; Govindan R
J Thorac Oncol; 2010 May; 5(5):741-6. PubMed ID: 20421767
[TBL] [Abstract][Full Text] [Related]
11. Reliably basing conclusions on subgroups of randomized clinical trials.
Koch A; Framke T
J Biopharm Stat; 2014; 24(1):42-57. PubMed ID: 24392977
[TBL] [Abstract][Full Text] [Related]
12. A new and rapid scoring system to assess the scientific evidence from clinical trials.
Silber S
J Interv Cardiol; 2006 Dec; 19(6):485-92. PubMed ID: 17107362
[TBL] [Abstract][Full Text] [Related]
13. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
[TBL] [Abstract][Full Text] [Related]
14. Adjusted significance levels for subgroup analyses in clinical trials.
Spiessens B; Debois M
Contemp Clin Trials; 2010 Nov; 31(6):647-56. PubMed ID: 20832503
[TBL] [Abstract][Full Text] [Related]
15. Evidence based evaluation of immuno-coagulatory interventions in critical care.
Afshari A
Dan Med Bull; 2011 Sep; 58(9):B4316. PubMed ID: 21893014
[TBL] [Abstract][Full Text] [Related]
16. HIV/AIDS: a minority health issue.
Cargill VA; Stone VE
Med Clin North Am; 2005 Jul; 89(4):895-912. PubMed ID: 15925655
[TBL] [Abstract][Full Text] [Related]
17. Considering race/ethnicity and socio-economic status in randomized controlled trials. A commentary on Frampton et al.'s systematic review generalizing trial findings and tackling health disparities in asthma research.
Kreatsoulas C; Anand S
Soc Sci Med; 2009 Oct; 69(8):1155-6. PubMed ID: 19640625
[No Abstract] [Full Text] [Related]
18. Adding more muscle and nerve to clinical trials.
Conwit RA; Bhanushali MJ; Porter JD; Kaufmann P; Gutmann L
Muscle Nerve; 2011 Nov; 44(5):695-702. PubMed ID: 22006684
[TBL] [Abstract][Full Text] [Related]
19. Regulatory perspectives on multiplicity in adaptive design clinical trials throughout a drug development program.
Wang SJ; Hung HM; O'Neill R
J Biopharm Stat; 2011 Jul; 21(4):846-59. PubMed ID: 21516573
[TBL] [Abstract][Full Text] [Related]
20. Investigators' assessment of NIH mandated inclusion of women and minorities in research.
Corbie-Smith GM; Durant RW; St George DM
Contemp Clin Trials; 2006 Dec; 27(6):571-9. PubMed ID: 16843069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
